Expanding Treatment Options for HER2+ Breast Cancer

June 30, 2020
Adam Brufsky, MD, PhD, UPMC Hillman Cancer Center

,
Carey K. Anders, MD, Duke Cancer Institute

,
Virginia Kaklamani, MD, University of Texas Health Science Center

,
Rashmi K. Murthy, MD, MBE, MD Anderson Cancer Center

,
Mark D. Pegram, MD, Stanford Cancer Center


Related Content:

Peer Exchange | Breast Cancer

x